News
Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early next year. | Wegovy-maker Novo Nordisk is moving its investigational ...
The use of pathological response to neoadjuvant chemotherapy to guide the use of regional nodal irradiation expands the clinical utility of the neoadjuvant approach.
BriaCell Reports "Late-Breaker" Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified ...
Phase Ib/II data (NCT05078866 5) demonstrated the safety of NOUS-209 and its ability to stimulate potent immune responses in LS carriers, supporting its advancement into a potentially ...
A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously unknown phase of the immune response. The results, published in ...
Therefore, phase responses for several types of hydrophones may be inferred from measurements of their magnitude responses. Calculation of phase response based on magnitude response using the ...
Interestingly, phase separation persisted in Opto-Kindlin-2 R290K upon blue light exposure, although to a much weaker extent than the wild-type form, indicating the importance of the charge of R290 ...
A phase 2 study to determine the pathological (path) response to neoadjuvant nivolumab (nivo) and relatlimab (rela) in stage I to III resectable Merkel cell carcinoma (Neo-MCC).
Data analysis is an integral part of modern data-driven decision-making, encompassing a broad array of techniques and tools to process, visualize, and interpret data. Python, a versatile programming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results